HEMATOLOGY TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-25696 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Hematology Testing Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL HEMATOLOGY TESTING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL HEMATOLOGY TESTING MARKET
7.1 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL HEMATOLOGY TESTING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA HEMATOLOGY TESTING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Abbott Laboratories
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Beckman Coulter, Inc. (a subsidiary of Danaher Corporation (U.S.)
16.3 Bio-Rad Laboratories, Inc.
16.4 Boule Diagnostics AB
16.5 Horiba, Ltd.
16.6 Mindray Medical International Limited
16.7 Nihon Kohden Corporation
16.8 Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
16.9 Siemens Healthcare (a division of Siemens AG)
16.10 Sysmex Corporation
16.11 AGAPPE DIAGNOSTICS
16.12 B&E BIO-TECHNOLOGY
16.13 Balio Diagnostics
16.14 CLINDIAG SYSTEMS
16.15 Convergent Technologies
16.16 CPC Diagnostics
16.17 CPM Scientifica
16.18 DIAGON
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Products and ServicesHematology Products
  o Hematology Instruments
  o Hematology Analyzers
      o Hematology Analyzers, by Type of Automation
           o Fully Automated Hematology Analyzers
           o 5-part and 6-part Differential Hematology Analyzers
           o 3-part Differential Hematology Analyzers
           o Semi-automated Hematology Analyzers
      o Hematology Analyzers, by Complexity
           o Highly Complex Clinical Laboratory Analyzers
           o Hematology Analyzers for Point-of-Care Testing
      o Hematology Analyzers, by Price Range
           o High-end Hematology Analyzers
           o Low-range and Mid-range Hematology Analyzers
           o Slide Stainers/Markers
  o Hematology Consumables
      o Hematology Reagents
      o Hematology Stains
      o Controls and Calibrators
  o Others
Hematology Services
  o Simple Dripping
  o Electrostatic Dripping
  o Coaxial Airflow
  o Liquid-jet Break Up
  o Vibrating-jet Technique
  o Jet cutting Technique
  o Rotating Disk Atomization
By Type of Tests  
Complete Blood Count Analysis
 o Hemoglobin Concentration
 o Hematocrit Determination
 o Red Blood Cell Count
 o Red Cell Indices
 o Red Cell Size Histograms
 o Other Tests
White Blood Cell Analysis
Reticulocytes
Hemoglobin Test
Platelet Function Tests
Erythrocyte Sedimentation Rate/CRP
Red Cell Analysis
Hemocysteine Test
Neutrophil Function Tests
Bone Marrow Analysis
Red Cell Deformability
2, 3-bisphosphoglycerate (2, 3-DPG) Test
Other Tests
By End User
Clinical Testing Laboratories
Stand-alone Hospitals
Research Institutions
   o Public and Private Research Centers
   o Academic Institutions
Commercial Organizations
Companies
Abbott Laboratories
Beckman Coulter, Inc. (a subsidiary of Danaher Corporation (U.S.)
Bio-Rad Laboratories, Inc.
Boule Diagnostics AB
Horiba, Ltd.
Mindray Medical International Limited
Nihon Kohden Corporation
Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
Siemens Healthcare (a division of Siemens AG)
Sysmex Corporation
AGAPPE DIAGNOSTICS
B&E BIO-TECHNOLOGY
Balio Diagnostics
CLINDIAG SYSTEMS
Convergent Technologies
CPC Diagnostics
CPM Scientifica
DIAGON
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.